Revive Therapeutics's total assets for Q3 2024 were C$9.63M, a decrease of -0.90% from the previous quarter. TSE:RVV total liabilities were C$3.69M for the fiscal quarter, a 11.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.